Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 13
2024
|
Karen Mc Loughlin Director |
BUY
Open market or private purchase
|
Direct |
25,000
+25.47%
|
$50,000
$2.2 P/Share
|
Dec 11
2024
|
Silvana Battaglia Director |
BUY
Open market or private purchase
|
Direct |
25,062
+27.48%
|
$50,124
$2.01 P/Share
|
Dec 09
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
7,500
+11.31%
|
$15,000
$2.2 P/Share
|
Dec 05
2024
|
John William Wulf Director |
BUY
Open market or private purchase
|
Direct |
45,000
+17.92%
|
$90,000
$2.18 P/Share
|
Nov 25
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
12,500
+19.59%
|
$25,000
$2.28 P/Share
|
Sep 12
2024
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
20,000
+22.83%
|
$60,000
$3.36 P/Share
|
Aug 16
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.69%
|
$1,620
$4.85 P/Share
|
Jul 01
2024
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
659,880
+27.35%
|
-
|
May 29
2024
|
Silvana Battaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+43.88%
|
-
|
May 29
2024
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+2.46%
|
-
|
May 29
2024
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+33.4%
|
-
|
May 29
2024
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+16.62%
|
-
|
May 29
2024
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+40.01%
|
-
|
May 29
2024
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+45.28%
|
-
|
May 29
2024
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+0.89%
|
-
|
May 24
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-0.32%
|
$1,122
$6.09 P/Share
|
Apr 15
2024
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,108
+42.44%
|
-
|
Apr 15
2024
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,041
+41.54%
|
-
|
Apr 15
2024
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
252,243
+42.86%
|
-
|
Apr 15
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,189
+28.07%
|
-
|
Apr 15
2024
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,189
+30.13%
|
-
|
Apr 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,056
-2.01%
|
$12,224
$4.95 P/Share
|
Apr 14
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-1.37%
|
$3,240
$4.95 P/Share
|
Apr 14
2024
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,978
-9.17%
|
$15,912
$4.95 P/Share
|
Apr 14
2024
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,875
-2.34%
|
$31,500
$4.95 P/Share
|
Apr 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,817
-0.96%
|
$19,268
$4.95 P/Share
|
Apr 14
2024
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,506
-1.21%
|
$22,024
$4.95 P/Share
|
Mar 14
2024
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,751
-13.47%
|
$33,755
$5.23 P/Share
|
Mar 14
2024
|
Timothy Bensley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,945
+22.97%
|
-
|
Mar 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,900
-1.57%
|
$24,500
$5.23 P/Share
|
Mar 14
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Open market or private purchase
|
Direct |
11,956
+3.7%
|
-
|
Mar 14
2024
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
95,266
-26.91%
|
$476,330
$5.23 P/Share
|
Mar 14
2024
|
Benjamin Shaker Chief Markets Officer |
BUY
Open market or private purchase
|
Direct |
274,455
+43.67%
|
-
|
Mar 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,883
-4.5%
|
$9,415
$5.23 P/Share
|
Mar 14
2024
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
5,434
+11.5%
|
-
|
Mar 14
2024
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,883
-2.94%
|
$9,415
$5.23 P/Share
|
Mar 14
2024
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Open market or private purchase
|
Direct |
5,434
+7.83%
|
-
|
Jan 05
2024
|
Ronald A Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100,000
+12.9%
|
$2,200,000
$2.0 P/Share
|
Nov 29
2023
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
22,300
+41.12%
|
$245,300
$11.22 P/Share
|
Nov 21
2023
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
44,690
+48.43%
|
$491,590
$11.14 P/Share
|
Sep 13
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.0 P/Share
|
Sep 13
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+16.02%
|
$56,250
$3.79 P/Share
|
Sep 12
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.05 P/Share
|
Sep 12
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+16.02%
|
$56,250
$3.79 P/Share
|
Sep 11
2023
|
Timothy Gertsch Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
26,250
-42.18%
|
$472,500
$18.62 P/Share
|
Sep 11
2023
|
Timothy Gertsch Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,250
+29.42%
|
$157,500
$6.75 P/Share
|
Aug 16
2023
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,603
+24.66%
|
-
|
Aug 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.1 P/Share
|
Aug 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+16.02%
|
$56,250
$3.79 P/Share
|
Aug 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.72 P/Share
|